As of Jun 27
| -0.04 / -1.96%|
The 7 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +650.00% increase from the last price of 2.00.
The current consensus among 6 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.